Antibodies against charged subfractions of LDLs are associated with disturbed ankle-brachial index and cardiovascular risk factors in a Japanese-Brazilian population with high prevalence of dislipidemias

International Journal of Atherosclerosis

Volumn 2, Issue 1, 2007, Pages 68-74

  de Siqueira, Antonela Ferro Antunes ^a,c   Osiro, K ^a   Hirai, A T ^a   Abdalla, D A P ^b   Ferreira, S R G ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Ankle brachial index; Cardiovascular risk factors; Dyslipidemia; LDL antibodies; Peripheral aterial disease

Indexed keywords

C REACTIVE PROTEIN; CREATININE; LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGE; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; ATHEROGENESIS; BRAZIL; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DYSLIPIDEMIA; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IN VIVO STUDY; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 77953463916     PISSN: 18092942     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lopes-Virella MF, Virella G. Atherosclerosis and autoimmunity. Clin Immunol Immunopathol. 1994 Feb;73(2):155-67.
2. Siqueira AFA, Gimeno SGA, Hirai AT, Franco LJ, Ferreira SRG. [Marcante prevalência de dislipidemia em população nipo-brasileira de Bauru]. Arq Bras Endocrinol Metab. 2006;50 Suppl 2:S174 (in Portuguese).
3. Siqueira AFA, Gimeno SGA, Matsumura LK, Barros Jr N, Ferreira SRG. Macrovascular disease in a Japanese-Brazilian population of high prevalence of metabolic syndrome: associations with classical and non-classical risk factors. Atherosclerosis. In press.
4. Sanchez-Quesada JL, Benitez S, Ordonez-Llanos J. Electronegative low-density lipoprotein. Curr Opin Lipidol. 2004 Jun;15(3):329-35.
5. Siqueira AFA, Abdalla, DSP, Ferreira SRG. [LDL: from metabolic syndrome to instability of the atherosclerotic plaque]. Arq Bras Endocrinol Metabol. 2006 Apr; 50(2): 334-43.
6. Avogaro P, Bon GB. Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 1988 Feb;8(91):79-87.
7. Apolinario EFS, Pereira EC, Bertolami MC, Faludi A, Monte O, Gagliardi AR, Xavier HT, Abdalla DSP. Minimally modified (electronegative) LDL- and anti-LDL- autoantibodies in diabetes mellitus and impaired glucose tolerance. Int J Atheroscler. 2006 March;1(1):42-7.
8. Oliveira JA, Sevanian A, Rodrigues RJ, Apolinario EFS, Abdalla DSP. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes. Clin Biochem. 2006 Jul 7;39(7):708-14.
9. Barros MRAC, Bertolami MC, Abdalla DSP, Ferreira WP. Identification of mildly oxidized low-density lipoprotein (electronegative LDL) and its auto-antibodies IgG in children and adolescents hypercholesterolemic offsprings. Atherosclerosis. 2006 Jan;184(1):103-7.
10. Monaco C, Crea F, Nicolli G, Summaria F, Cianflone D, Bordone R, Bellomo G, Maseri A. Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease. Phatophysiological implications. Eur Heart. J 2001 Sep;22(17):1572-7.
11. Piarulli F, Lapolla A, Sartore G, Rossetti C, Bax G, Noale M, Minicuci N, Fiore C, Marchioro L, Manzato E, Fedele D. Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes. Diabetes Care. 2005 Mar;28(3):653-7.
12. Gimeno SGA, Ferreira SRG, Franco LJ, Hirai AT, Matsumura LK, Moises RS. Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia.2002 Dec(12):135-8.
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Jr. Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 Jan: 83(7):499-511.
14. Griffin BA, Caslake MJ, Yip B, Tait GW, Packard CJ, Shepherd J. Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 1990 Jul;83(1):59-67.
15. Braunwald E. Shattuck Lecture-Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997 Nov;337(19):1360-9.
16. Wilson PW, Ben-Yehuda O, McNamara J, Massaro J, Witztum J and Reaven PD. Autoantibodies to oxidized LDL and cardiovascular risk: The Framingham Offspring Study. Atherosclerosis. In press.
17. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol. 1995 Apr;15(4):441-5.
18. Hulthe J, Wikstrand J, Lidell A, Wendelhag I, Hansson GK, Wiklund O. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1203-11.
19. Doo YC, Han SJ, Lee JH, Cho GY, Hong KS, Han KR, Lee NH, Oh DJ, Ryu KH, Rhim CY, Lee KH, Lee Y. Associations among oxidized low-density lipoprotein antibody, C-reactive protein, interleukin-6, and circulating cell adhesion molecules in patients with unstable angina pectoris. Am J Cardiol. 2004 Mar;93(5):554-8.
20. Lopes-Virella MF, Virella G. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes. 1992 Oct;41 Suppl 2:86-91.
21. Folsom AR, Chambless LE, Ballantyne CM., Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH, Jr. Sorlie P, Diao G, Sharrett AR. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006 Jul 10;166(13):1368-73.